Marianna buys NVO 44.61: Novo Nordisk A/Sâs âNeutralâ Rating Reaffirmed at Zacks (NVO)
Novo Nordisk A/S (NYSE:NVO)âs stock had its âneutralâ rating reaffirmed by Zacks in a note issued to investors on Tuesday. They currently have a $47.00 target price on the stock. Zacksâs price target indicates a potential upside of 6.09% from the . ... ...
26 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home